Medication Appropriateness, Polypharmacy, and Drug-Drug Interactions in Ambulatory Elderly Patients with Cardiovascular Diseases at Tikur Anbessa Specialized Hospital, Ethiopia

References

• United Nations. Department of Economic and Social Affairs, Population Division. World population ageing 2019: highlights (ST/ESA/SER.A/430); 2019.
   Google Scholar
• Carneiro JA, Cardoso RR, Durães MS, et al. Frailty in the elderly: prevalence and associated factors. Rev Bras Enferm. 2017;70(4):747–752. PubMed PMID: 28793104. doi:10.1590/0034-7167-2016-0633
   PubMed Web of Science ®Google Scholar
• Su BB, Ma JX, Song W, Yuan J, Dong XY, Wan J. [Analysis of comorbidity and polypharmacy in middle-aged and elderly patients]. Zhonghua Yi Xue Za Zhi. 2020;100(25):1983–1987. PubMed PMID: 32629601. Chinese. doi:10.3760/cma.j.cn112137-20200403-01066
   PubMedGoogle Scholar
• Preparing for an aging World. The case for Cross-National Research. Washington (DC): National Academies Press (US); 2001. 6, The Health of Aging Populations. Available from: https://www.ncbi.nlm.nih.gov/books/NBK98373/. Accessed April 14, 2022.
   Google Scholar
• Berrut G, de Decker L. [Comprehensive assessment of comorbidity in the elderly]. Geriatr Psychol Neuropsychiatr Vieil. 2015;13(Suppl 1):7–12. PubMed PMID: 26345582. French. doi:10.1684/pnv.2015.0543
   Web of Science ®Google Scholar
• Strait JB, Lakatta EG. Aging-associated cardiovascular changes and their relationship to heart failure. Heart Fail Clin. 2012;8(1):143–164. PubMed PMID: 22108734. doi:10.1016/j.hfc.2011.08.011
   PubMed Web of Science ®Google Scholar
• Kane AE, Howlett SE. Differences in cardiovascular aging in men and women. Adv Exp Med Biol. 2018;1065:389–411. PubMed PMID: 30051398. doi:10.1007/978-3-319-77932-4_25
   PubMed Web of Science ®Google Scholar
• World Health Organization. Cardiovascular diseases. Available from: https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1. Accessed April 14, 2022.
   Google Scholar
• Roman YM, Dixon DL, Salgado TM, et al. Challenges in pharmacotherapy for older adults: a framework for pharmacogenomics implementation. Pharmacogenomics. 2020;21(9):627–635. PubMed PMID: 32425117. doi:10.2217/pgs-2019-0198
   PubMed Web of Science ®Google Scholar
• Martínez-Arroyo JL, Gómez-García A, Sauceda-Martínez D. [Polypharmacy prevalence and potentially inappropriate drug prescription in the elderly hospitalized for cardiovascular disease]. Gac Med Mex. 2014;150(Suppl 1):29–38. Norwegian.
   PubMedGoogle Scholar
• Stuhec M, Flegar I, Zelko E, Kovačič A, Zabavnik V. Clinical pharmacist interventions in cardiovascular disease pharmacotherapy in elderly patients on excessive polypharmacy: a retrospective pre-post observational multicentric study. Wien Klin Wochenschr. 2021;133(15–16):770–779. PubMed PMID: 33471149. doi:10.1007/s00508-020-01801-y
   PubMed Web of Science ®Google Scholar
• Assefa YA, Kedir A, Kahaliw W. Survey on polypharmacy and drug-drug interactions among elderly people with cardiovascular diseases at yekatit 12 hospital, Addis Ababa, Ethiopia. Integr Pharm Res Pract. 2020;9:1–9. PubMed PMID: 32021833. doi:10.2147/IPRP.S231286
   PubMed Web of Science ®Google Scholar
• Björkman IK, Fastbom J, Schmidt IK, Bernsten CB. Drug—Drug Interactions in the Elderly. Ann Pharmacother. 2002;36(11):1675–1681. doi:10.1345/aph.1A484
   PubMed Web of Science ®Google Scholar
• Ahmad A, Mast MR, Nijpels G, Elders PJ, Dekker JM, Hugtenburg JG. Identification of drug-related problems of elderly patients discharged from hospital. Patient Prefer Adherence. 2014;8:155–165. PubMed PMID: 24523581. doi:10.2147/PPA.S48357
   PubMed Web of Science ®Google Scholar
• Davies EA, O’Mahony MS. Adverse drug reactions in special populations – the elderly. Br J Clin Pharmacol. 2015;80(4):796–807. doi:10.1111/bcp.12596
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society. 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694. PubMed PMID: 30693946. doi:10.1111/jgs.15767
   PubMed Web of Science ®Google Scholar
• Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–1051. PubMed PMID: 1474400. doi:10.1016/0895-4356(92)90144-c
   PubMed Web of Science ®Google Scholar
• Spinewine A, Dumont C, Mallet L, Swine C. MEDICATION APPROPRIATENESS INDEX: RELIABILITY AND RECOMMENDATIONS FOR FUTURE USE. J Am Geriatr Soc. 2006;54(4):720–722. doi:10.1111/j.1532-5415.2006.00668_8.x
   PubMed Web of Science ®Google Scholar
• Angaw DA, Ali R, Tadele A, Shumet S. The prevalence of cardiovascular disease in Ethiopia: a systematic review and meta-analysis of institutional and community-based studies. BMC Cardiovasc Disord. 2021;21(1):37. doi:10.1186/s12872-020-01828-z
   PubMed Web of Science ®Google Scholar
• Ali S, Misganaw A, Worku A, et al. The burden of cardiovascular diseases in Ethiopia from 1990 to 2017: evidence from the Global Burden of Disease Study. Int Health. 2020;13(4):318–326. doi:10.1093/inthealth/ihaa069
   Web of Science ®Google Scholar
• Lemma W, Islam M, Loha E. Potentially inappropriate medication prescribing patterns in geriatric patients in a health facility in Addis Ababa, Ethiopia. Trop J Pharm Res. 2020;19(11):2441–2446.
   Web of Science ®Google Scholar
• Bhagavathula AS, Seid MA, Adane A, Gebreyohannes EA, Brkic J, Fialová D. Prevalence and determinants of multimorbidity, polypharmacy, and potentially inappropriate medication use in the older outpatients: findings from EuroAgeism H2020 ESR7 Project in Ethiopia. Pharmaceuticals. 2021;14(9):844. doi:10.3390/ph14090844
   Web of Science ®Google Scholar
• Tesfaye BT, Tessema MT, Yizengaw MA, Bosho DD. Potentially inappropriate medication use among older adult patients on follow-up at the chronic care clinic of a specialized teaching hospital in Ethiopia. A cross-sectional study. BMC Geriatr. 2021;21(1):530. doi:10.1186/s12877-021-02463-9
   PubMed Web of Science ®Google Scholar
• Sheikh-Taha M, Dimassi H. Potentially inappropriate home medications among older patients with cardiovascular disease admitted to a cardiology service in USA. BMC Cardiovasc Disord. 2017;17(1):189. doi:10.1186/s12872-017-0623-1
   PubMed Web of Science ®Google Scholar
• Lopez-Rodriguez JA, Rogero-Blanco E, Aza-Pascual-Salcedo M, et al. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: a cross-sectional study. PLoS One. 2020;15(8):e0237186. doi:10.1371/journal.pone.0237186
   PubMed Web of Science ®Google Scholar
• Awad A, Hanna O, Van Dijk L. Potentially inappropriate medication use among geriatric patients in primary care setting: a cross-sectional study using the Beers, STOPP, FORTA and MAI criteria. PLoS One. 2019;14(6):e0218174. PubMed PMID: 31194800; PubMed Central PMCID: PMCPMC6563997. doi:10.1371/journal.pone.0218174
   PubMed Web of Science ®Google Scholar
• Abegaz TM, Birru EM, Mekonnen GB, Marengoni A. Potentially inappropriate prescribing in Ethiopian geriatric patients hospitalized with cardiovascular disorders using START/STOPP criteria. PLoS One. 2018;13(5):e0195949. doi:10.1371/journal.pone.0195949
   PubMed Web of Science ®Google Scholar
• Di Martino E, Provenzani A, Polidori P, De Luca V. Evidence-based application of explicit criteria to assess the appropriateness of geriatric prescriptions at admission and hospital stay. PLoS One. 2020;15(8):e0238064. doi:10.1371/journal.pone.0238064
   PubMed Web of Science ®Google Scholar
• Slabaugh SL, Maio V, Templin M, Abouzaid S. Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy. Drugs Aging. 2010;27(12):1019–1028. PubMed PMID: 21087071. doi:10.2165/11584990-000000000-00000
   PubMed Web of Science ®Google Scholar
• Sheikh-Taha M, Asmar M. Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States. BMC Geriatr. 2021;21(1):233. doi:10.1186/s12877-021-02183-0
   PubMed Web of Science ®Google Scholar
• de Oliveira LM, Diel J, Nunes A, Dal Pizzol TDS. Prevalence of drug interactions in hospitalised elderly patients: a systematic review. Eur J Hosp Pharm. 2021;28(1):4–9. PubMed PMID: 33355278; PubMed Central PMCID. doi:10.1136/ejhpharm-2019-002111
   PubMedGoogle Scholar
• van Heerden JA, Burger JR, Gerber JJ, Vlahović-Palčevski V. Prevalence of potentially serious drug-drug interactions among South African elderly private health sector patients using the Mimica Matanović/Vlahović-Palčevski protocol. Int J Pharm Pract. 2018;26(2):156–164. PubMed PMID: 28665037. doi:10.1111/ijpp.12383
   PubMed Web of Science ®Google Scholar
• Cvetković Z, Perić A, Dobrić S. Potentially Inappropriate prescribing and potential clinically significant drug-drug interactions in older outpatients: is there any association? Medicina. 2019;55(7):332. PubMed PMID: 31277258; PubMed Central PMCID: PMCPMC6680842. doi:10.3390/medicina55070332
   PubMed Web of Science ®Google Scholar
• Cool C, Cestac P, Laborde C, et al. Potentially inappropriate drug prescribing and associated factors in nursing homes. J Am Med Dir Assoc. 2014;15(11):850.e1–9. PubMed PMID: 25284165. doi:10.1016/j.jamda.2014.08.003
   PubMed Web of Science ®Google Scholar